Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, providing promising enhancements throughout several health care and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer, additional trustworthy substitute for therapeu